Angelica Loskog
InvestorScientific adviser at NXT2B
About
Angelica is CEO of Lokon Pharma AB and a Professor of Immunotherapy at Uppsala University, working in immune, gene and cell therapy with a focus on cancer and autoimmune disease.
Colleagues at NXT2B
Frequently asked questions
- Who is Angelica Loskog?
- Angelica is CEO of Lokon Pharma AB and a Professor of Immunotherapy at Uppsala University, working in immune, gene and cell therapy with a focus on cancer and autoimmune disease.
- Where does Angelica Loskog work?
- Angelica Loskog is Scientific adviser at NXT2B.